يحاول ذهب - حر
Geopolitical risks not that strong to challenge RBI's rate cut logic
June 25, 2025
|Mint Ahmedabad
I would say Indian equities are fully valued. The Nifty is trading at about 21x one-year forward earnings R. Janakiraman CIO-emerging markets India, Franklin Templeton
Investors don't seem overly spooked by the geopolitical situation, said R. Janakiraman, chief investment officer-emerging markets India, Franklin Templeton Asset Management (India) Pvt. Ltd, which manages equity assets worth ₹1.04 trillion as of May end.
The recent geopolitical risks do not seem strong enough to derail the Reserve Bank of India's (RBI) rate cut logic, he told Mint in an interview.
But, he said that if the tensions escalated significantly, then India's risk premium could rise.
Besides, he believes a key risk to equity returns in 2025 is the heavy supply from initial public offerings (IPOs), qualified institutional placements (QIPs) and promoter sell-downs, a trend that surfaced in late 2024 and contributed to the market's decline.
Edited excerpts:
Are the recent tensions between Iran and Israel making clients anxious about investing in equities?
It is still early, so I haven't surveyed clients informally yet on their reaction to geopolitical tensions. I suspect they view it through market performance—if markets stay stable, concerns remain low. So far, markets have been fairly resilient, keeping nervousness among Indian investors limited. If news like rising crude prices hits, nervousness could increase. How investors react in such scenarios remains to be seen, but for now, they don't seem overly spooked by the geopolitical situation.
How seriously could this West Asia conflict impact the Indian markets, especially in view of the US involvement?
There are two ways to look at the ongoing West Asia tensions. In the short term, geopolitical risks have risen, but market reactions—especially in oil—suggest concerns are limited. Oil futures for the next 6-12 months have returned to pre-conflict levels, suggesting that the spike is expected to be temporary.
هذه القصة من طبعة June 25, 2025 من Mint Ahmedabad.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Ahmedabad
Mint Ahmedabad
'If you're on trend, you are in trouble'
Patou creative head Guillaume Henry discusses the essence of couture and why simple is best
4 mins
December 13, 2025
Mint Ahmedabad
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Ahmedabad
Chair man, of the bored
STREAM OF STORIES
3 mins
December 13, 2025
Mint Ahmedabad
Anju Dodiya creates disquieting worlds
Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'
5 mins
December 13, 2025
Mint Ahmedabad
Bar hopping with Lounge
\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.
1 mins
December 13, 2025
Mint Ahmedabad
New Delhi and France revise 1992 tax treaty
India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.
1 min
December 13, 2025
Mint Ahmedabad
Ozempic debuts with a ₹2,200-a-week price tag
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
1 mins
December 13, 2025
Mint Ahmedabad
How 'puri-aloo' and 'chaat' unite Lucknow
Whenever my friends want to eat puri-aloo, they invite themselves over to my home.
5 mins
December 13, 2025
Mint Ahmedabad
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Ahmedabad
Govt’s insurance reform allows 100% FDI, composite licences
The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.
1 mins
December 13, 2025
Listen
Translate
Change font size
